JBIO (JBIO) reported G&A of $7.39M in Q1 2026.

How has JBIO's G&A changed year-over-year?

JBIO's G&A increased by 119.9% year-over-year, from $3.36M to $7.39M.

What is the long-term trend for JBIO's G&A?

Over 4 years (2021 to 2025), JBIO's G&A has grown at a 26.3% compound annual growth rate (CAGR), from $8.04M to $20.42M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

JBIO JBIO G&A

G&A at other companies

Vera TherapeuticsVERA

$39.12M+146%

AnaptysBio, Inc.ANAB

$26.2M+85.4%

Avalo TherapeuticsAVTX

$6.85M+23.6%

Cullinan Therapeutics, Inc.CGEM

$11.57M-14.5%

Vor BiopharmaVOR

$17.57M+167%

AnnexonANNX

$10.27M+11.3%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's G&A?: JBIO (JBIO) reported G&A of $7.39M in Q1 2026.
How has JBIO's G&A changed year-over-year?: JBIO's G&A increased by 119.9% year-over-year, from $3.36M to $7.39M.
What is the long-term trend for JBIO's G&A?: Over 4 years (2021 to 2025), JBIO's G&A has grown at a 26.3% compound annual growth rate (CAGR), from $8.04M to $20.42M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.